Immortalised breast epithelia survive prolonged DNA replication stress and return to cycle from a senescent-Like state

Cell Death and Disease

Volumn 5, Issue 7, 2014, Pages

  Maya Mendoza, A ^a,b   Merchut Maya, J M ^b   Bartkova, J ^b   Bartek, J ^b,c   Streuli, C H ^a   Jackson, D A ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b DANISH CANCER SOCIETY RESEARCH CENTER   (Denmark)

^c PALACKÝ UNIVERSITY   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; CHECKPOINT KINASE 1; CYCLIN D1; DNA DIRECTED DNA POLYMERASE ALPHA; HISTONE H2AX; PROTEIN P21; PROTEIN P53;

APOPTOSIS; ARTICLE; BREAST EPITHELIUM; BREAST REDUCTION; CELL CYCLE PROGRESSION; CELL DEATH; CELL FATE; CELL STRESS; CELL SURVIVAL; CHROMATIN; CHROMOSOME; CHROMOSOME DAMAGE; DIPLOIDY; DNA DAMAGE; DNA REPLICATION; DNA REPLICATION ORIGIN; EPITHELIUM CELL; FIBROBLAST; FLOW CYTOMETRY; HETEROCHROMATIN; HUMAN; HUMAN CELL; MCF 7 CELL LINE; PLASTICITY; PRIORITY JOURNAL; S PHASE CELL CYCLE CHECKPOINT; SENESCENCE; SINGLE CELL ANALYSIS; TELOMERE; BREAST TUMOR; CELL AGING; CELL CYCLE; CELL CYCLE S PHASE; CYTOLOGY; FEMALE; GENETICS; MAMMARY GLAND; PATHOPHYSIOLOGY; TUMOR CELL LINE;

BREAST NEOPLASMS; CELL AGING; CELL CYCLE; CELL LINE, TUMOR; CELL SURVIVAL; DNA DAMAGE; DNA REPLICATION; EPITHELIAL CELLS; FEMALE; HUMANS; MAMMARY GLANDS, HUMAN; S PHASE;

EID: 84905507784     PISSN: None     EISSN: 20414889     Source Type: Journal    
DOI: 10.1038/cddis.2014.315     Document Type: Article

References (69)

1. Kuilman T, Michaloglou C, Mooi WJ, Peeper DS. The essence of senescence. Genes Dev 2010; 24: 2463-2479.
2. Hayflick L. Limited in vitro lifetime of human diploid cell strains. Exp Cell Res 1965; 37: 614.
3. Matsumura T, Zerrudo Z, Hayflick L. Senescent human diploid cells in culture-Survival, DNA synthesis and morphology. J Gerontol 1979; 34: 328-334.
4. Kong Y, Cui H, Ramkumar C, Zhang H. Regulation of senescence in cancer and aging. J Aging Res 2011; 2011: 963172.
5. Campisi J. Aging, cellular senescence, and cancer. Ann Rev Physiol 2013; 75: 685-705.
6. Campisi J, di Fagagna FD. Cellular senescence: when bad things happen to good cells. Nat Rev Mol Cel Biol 2007; 8: 729-740.
7. Harley CB. Telomere loss-Mitotic clock or genetic time bomb. Mut Res 1991; 256: 271-282.
8. Aubert G, Lansdorp PM. Telomeres and aging. Physiol Rev 2008; 88: 557-579.
9. di Fagagna FD, Reaper PM, Clay-Farrace L, Fiegler H, Carr P, Von Zglinicki T et al. A DNA damage checkpoint response in telomere-Initiated senescence. Nature 2003; 426: 194-198.
10. di Fagagna FD. Living on a break: cellular senescence as a DNA-Damage response. Nat Rev Cancer 2008; 8: 512-522.
11. Roos WP, Kaina B. DNA damage-Induced cell death: from specific DNA lesions to the DNA damage response and apoptosis. Cancer Lett 2013; 332: 237-248.
12. Chandler H, Peters G. Stressing the cell cycle in senescence and aging. Curr Opin Cell Biol 2013; 25: 765-771.
13. Brown JP, Wei WY, Sedivy JM. Bypass of senescence after disruption of p21(CIP1/WAF1) gene in normal diploid human fibroblasts. Science 1997; 277: 831-834.
14. Stein GH, Drullinger LF, Soulard A, Dulic V. Differential roles for cyclin-Dependent kinase inhibitors p21 and p16 in the mechanisms of senescence and differentiation in human fibroblasts. Mol Cell Biol 1999; 19: 2109-2117.
15. Hara E, Smith R, Parry D, Tahara H, Stone S, Peters G. Regulation of p16(CDKN2) expression and its implications for cell immortalization and senescence. Mol Cell Biol 1996; 16: 859-867.
16. Kiyono T, Foster SA, Koop JI, McDougall JK, Galloway DA, Klingelhutz AJ. Both Rb/p16(INK4a) inactivation and telomerase activity are required to immortalize human epithelial cells. Nature 1998; 396: 84-88.
17. Beausejour CM, Krtolica A, Galimi F, Narita M, Lowe SW, Yaswen P et al. Reversal of human cellular senescence: roles of the p53 and p16 pathways. Embo J 2003; 22: 4212-4222.
18. Stingl J, Caldas C. Opinion-Molecular heterogeneity of breast carcinomas and the cancer stem cell hypothesis. Nat Rev Cancer 2007; 7: 791-799.
19. Mumcuoglu M, Bagislar S, Yuzugullu H, Alotaibi H, Senturk S, Telkoparan P et al. The Ability to Generate Senescent Progeny as a Mechanism Underlying Breast Cancer Cell Heterogeneity. PLoS One 2010; 5: e11288.
20. Romanov SR, Kozakiewicz BK, Holst CR, Stampfer MR, Haupt LM, Tlsty TD et al. Normal human mammary epithelial cells spontaneously escape senescence and acquire genomic changes. Nature 2001; 409: 633-637.
21. Salama R, Sadaie M, Hoare M, Narita M. Cellular senescence and its effector programs. Genes Dev 2014; 28: 99-114.
22. Goligorsky MS, Chen J, Patschan S. Stress-Induced premature senescence of endothelial cells: a perilous state between recovery and point of no return. Curr Opin Hematol 2009; 16: 215-219.
23. Tyson JJ, Novak B. Temporal organization of the cell cycle. Curr Biol 2008; 18: R759-R768.
24. Gerard C, Goldbeter A. Temporal self-Organization of the cyclin/Cdk network driving the mammalian cell cycle. Proc Natl Acad Sci USA 2009; 106: 21643-21648.
25. Lukas J, Lukas C, Bartek J. Mammalian cell cycle checkpoints: signalling pathways and their organization in space and time. DNA Repair 2004; 3: 997-1007.
26. Jackson SP, Bartek J. The DNA-Damage response in human biology and disease. Nature 2009; 461: 1071-1078.
27. Masai H, You ZY, Arai K. Control of DNA replication: regulation and activation of eukaryotic replicative helicase, MCM. IUBMB Life 2005; 57: 323-335.
28. Alfieri R, Barberis M, Chiaradonna F, Gaglio D, Milanesi L, Vanoni M et al. Towards a systems biology approach to mammalian cell cycle: modeling the entrance into S phase of quiescent fibroblasts after serum stimulation. BMC Bioinformatics 2009; 10(Suppl 12): S16.
29. Jung YS, Qian YJ, Chen XB. Examination of the expanding pathways for the regulation of p21 expression and activity. Cell Signal 2010; 22: 1003-1012.
30. Rudolph J. Cdc25 phosphatases: structure, specificity, and mechanism. Biochemistry 2007; 46: 3595-3604.
31. Sancar A, Lindsey-Boltz LA, Unsal-Kacmaz K, Linn S. Molecular mechanisms of mammalian DNA repair and the DNA damage checkpoints. Annu Rev Biochem 2004; 73: 39-85.
32. Vousden KH, Lane DP. p53 in health and disease. Nat Rev Mol Cell Biol 2007; 8: 275-283.
33. Hamada H, Tashima Y, Kisaka Y, Iwamoto K, Hanai T, Eguchi Y et al. Sophisticated framework between cell cycle arrest and apoptosis induction based on p53 dynamics. PLoS One 2009; 4: e4795.
34. Maya-Mendoza A, Petermann E, Gillespie DAF, Caldecott KW, Jackson DA. Chk1 regulates the density of active replication origins during the vertebrate S phase. Embo J 2007; 26: 2719-2731.
35. Ge XQ, Blow JJ. Chk1 inhibits replication factory activation but allows dormant origin firing in existing factories. J Cell Biol 2010; 191: 1285-1297.
36. Ge XQ, Jackson DA, Blow JJ. Dormant origins licensed by excess Mcm2-7 are required for human cells to survive replicative stress. Genes Dev 2007; 21: 3331-3341.
37. Blow JJ, Ge XQ, Jackson DA. How dormant origins promote complete genome replication. Trends Biochem Sci 2011; 36: 405-414.
38. Ilves I, Petojevic T, Pesavento JJ, Botchan MR. Activation of the MCM2-7 helicase by association with Cdc45 and GINS proteins. Mol Cell 2010; 37: 247-258.
39. Blow JJ, Dutta A. Preventing re-Replication of chromosomal DNA. Nat Rev Mol Cell Biol 2005; 6: 476-486.
40. Arias EE, Walter JC. Strength in numbers: preventing rereplication via multiple mechanisms in eukaryotic cells. Genes Dev 2007; 21: 497-518.
41. Truong LN, Wu XH. Prevention of DNA re-Replication in eukaryotic cells. J Mol Cell Biol 2011; 3: 13-22.
42. Chuang LC, Teixeira LK, Wohlschlegel JA, Henze M, Yates JR, Méndez J et al. Phosphorylation of Mcm2 by Cdc7 promotes pre-Replication complex assembly during cellcycle re-Entry. Mol Cell 2009; 35: 206-216.
43. Streuli CH. Integrins and cell-Fate determination. J Cell Sci 2009; 122: 171-177.
44. Jeanes AI, Maya-Mendoza A, Streuli CH. Cellular microenvironment influences the ability of mammary epithelia to undergo cell cycle. PLoS One 2011; 6: e18144.
45. Soule HD, Maloney TM, Wolman SR, Peterson Jr WD, Brenz R, McGrath CM et al. Isolation and characterization of a spontaneously immortalized human breast eoithelial cell line, MCF-10. Cancer Res 1990; 50: 6075-6086.
46. Cowell JK, LaDuca J, Rossi MR, Burkhardt T, Nowak NJ, Matsui S. Molecular characterization of the t(3;9) associated with immortalization in the MCF10A cell line. Cancer Genet Cytogenet 2005; 163: 23-29.
47. Borel F, Lacroix FB, Margolis RL. Prolonged arrest of mammalian cells at the G1/S boundary results in permanent S phase stasis. J Cell Sci 2002; 115: 2829-2838.
48. Bartek J, Lukas J. DNA damage checkpoints: from initiation to recovery or adaptation. Curr Opin Cell Biol 2007; 19: 238-245.
49. Di Micco R, Sulli G, Dobreva M, Liontos M, Botrugno OA, Gargiulo G et al. Interplay between oncogene-Induced DNA damage response and heterochromatin in senescence and cancer. Nat Cell Biol 2011; 13: 292-U244.
50. Lukas C, Savic V, Bekker-Jensen S, Doil C, Neumann B, Pedersen RS et al. 53BP1 nuclear bodies form around DNA lesions generated by mitotic transmission of chromosomes under replication stress. Nat Cell Biol 2011; 13: 243-U380.
51. Coller HA. What's taking so long? S-Phase entry from quiescence versus proliferation. Nat Rev Mol Cell Biol 2007; 8: 667-670.
52. Chien WW, Domenech C, Catallo R, Salles G, Ffrench M. S-Phase lengthening induced by p16(INK4a) overexpression in malignant cells with wild-Type pRb and p53. Cell Cycle 2010; 9: 3286-3296.
53. Mirzayans R, Andrais B, Scott A, Murray D. New insights into p53 signaling and cancer cell response to DNA damage: implications for cancer therapy. J Biomed Biotechnol 2012; 2012: 170325.
54. Elmore LW, Di X, Dumur C, Holt SE, Gewirtz DA. Evasion of a single-Step, chemotherapyinduced senescence in breast cancer cells: Implications for treatment response. Clin Cancer Res 2005; 11: 2637-2643.
55. Roberson RS, Kussick SJ, Vallieres E, Chen SYJ, Wu DY. Escape from therapy-Induced accelerated cellular senescence in p53-Null lung cancer cells and in human lung cancers. Cancer Res 2005; 65: 2795-2803.
56. Michishita E, Nakabayashi K, Ogino H, Suzuki T, Fujii M, Ayusawa D. DNA topoisomerase inhibitors induce reversible senescence in normal human fibroblasts. Biochem Biophys Res Commun 1998; 253: 667-671.
57. Syljuasen RG. Checkpoint adaptation in human cells. Oncogene 2007; 26: 5833-5839.
58. Petermann E, Orta ML, Issaeva N, Schultz N, Helleday T. Hydroxyurea-Stalled replication forks become progressively inactivated and require two different RAD51-Mediated pathways for restart and repair. Mol Cell 2010; 37: 492-502.
59. Debatisse M, Le Tallec B, Letessier A, Dutrillaux B, Brison O. Common fragile sites: mechanisms of instability revisited. Trends Genet 2012; 28: 22-32.
60. Halazonetis TD, Gorgoulis VG, Bartek J. An oncogene-Induced DNA damage model for cancer development. Science 2008; 319: 1352-1355.
61. Di Micco R, Fumagalli M, Cicalese A, Piccinin S, Gasparini P, Luise C et al. Oncogene-Induced senescence is a DNA damage response triggered by DNA hyperreplication. Nature 2006; 444: 638-642.
62. Bartkova J, Rezaei N, Liontos M, Karakaidos P, Kletsas D, Issaeva N et al. Oncogene-Induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints. Nature 2006; 444: 633-637.
63. Bester AC, Roniger M, Oren YS, Im MM, Sarni D, Chaoat M et al. Nucleotide deficiency promotes genomic instability in early stages of cancer development. Cell 2011; 145: 435-446.
64. Stoeber K, Tlsty TD, Happerfield L, Thomas GA, Romanov S, Bobrow L et al. DNA replication licensing and human cell proliferation. J Cell Sci 2001; 114: 2027-2041.
65. Shetty A, Loddo M, Fanshawe T, Prevost AT, Sainsbury R, Williams GH et al. DNA replication licensing and cell cycle kinetics of normal and neoplastic breast. Br J Cancer 2005; 93: 1295-1300.
66. Harmes DC, DiRenzo J. Cellular quiescence in mammary stem cells and breast tumor stem cells: got testable hypotheses? J Mammary Gland Biol Neoplasia 2009; 14: 19-27.
67. Lee MJ, Ye AS, Gardino AK, Heijink AM, Sorger PK, MacBeath G et al. Sequential application of anticancer drugs enhances cell death by rewiring apoptotic signaling networks. Cell 2012; 149: 780-794.
68. Taylorpapadimitriou J, Stampfer M, Bartek J, Lewis A, Boshell M, Lane EB et al. Keratin expression in human mammary epithelial cells cultured from normal and malignant tissue-Relation to in vivo phenotypes and influence of medium. J Cell Sci 1989; 94: 403-413.
69. Jackson DA, Pombo A. Replicon clusters are stable units of chromosome structure: Evidence that nuclear organization contributes to the efficient activation and propagation of S phase in human cells. J Cell Biol 1998; 140: 1285-1295.